These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18930961)

  • 1. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.
    Shah T; Casas JP; Cooper JA; Tzoulaki I; Sofat R; McCormack V; Smeeth L; Deanfield JE; Lowe GD; Rumley A; Fowkes FG; Humphries SE; Hingorani AD
    Int J Epidemiol; 2009 Feb; 38(1):217-31. PubMed ID: 18930961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
    Yeboah J; McClelland RL; Polonsky TS; Burke GL; Sibley CT; O'Leary D; Carr JJ; Goff DC; Greenland P; Herrington DM
    JAMA; 2012 Aug; 308(8):788-95. PubMed ID: 22910756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study.
    Nishimura K; Okamura T; Watanabe M; Nakai M; Takegami M; Higashiyama A; Kokubo Y; Okayama A; Miyamoto Y
    J Atheroscler Thromb; 2014; 21(8):784-98. PubMed ID: 24671110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.
    Wilson PW; Pencina M; Jacques P; Selhub J; D'Agostino R; O'Donnell CJ
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):92-7. PubMed ID: 20031795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis.
    Yeboah J; Carr JJ; Terry JG; Ding J; Zeb I; Liu S; Nasir K; Post W; Blumenthal RS; Budoff MJ
    Eur J Prev Cardiol; 2014 Oct; 21(10):1233-41. PubMed ID: 23689526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of a Coronary Heart Disease Risk Prediction Gene Score in UK Healthy Middle Aged Men and in the Pakistani Population.
    Beaney KE; Cooper JA; Ullah Shahid S; Ahmed W; Qamar R; Drenos F; Crockard MA; Humphries SE
    PLoS One; 2015; 10(7):e0130754. PubMed ID: 26133560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for heart disease: C-reactive protein versus coronary artery calcium.
    Patel AA; Budoff MJ
    Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):125-31. PubMed ID: 20014938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of novel risk factors in predicting risk of ischemic cardiovascular diseases in middle aged men in twenty years in Shanghai].
    Jin X; Zhou J; Zhou J; Pan X; Chen H; Ge J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):335-8. PubMed ID: 27005531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study.
    Rana JS; Cote M; Després JP; Sandhu MS; Talmud PJ; Ninio E; Wareham NJ; Kastelein JJ; Zwinderman AH; Khaw KT; Boekholdt SM
    Heart; 2009 Oct; 95(20):1682-7. PubMed ID: 19587389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.
    Buckley DI; Fu R; Freeman M; Rogers K; Helfand M
    Ann Intern Med; 2009 Oct; 151(7):483-95. PubMed ID: 19805771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
    Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.
    Shiffman D; O'Meara ES; Rowland CM; Louie JZ; Cushman M; Tracy RP; Devlin JJ; Psaty BM
    BMC Cardiovasc Disord; 2011 Mar; 11():10. PubMed ID: 21406102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.
    Shah N; Parikh V; Patel N; Patel N; Badheka A; Deshmukh A; Rathod A; Lafferty J
    Int J Cardiol; 2014 Feb; 171(3):390-7. PubMed ID: 24388541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Evans CV; Johnson E; Redmond N; Coppola EL; Smith N
    JAMA; 2018 Jul; 320(3):281-297. PubMed ID: 29998301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.
    Herder C; Baumert J; Zierer A; Roden M; Meisinger C; Karakas M; Chambless L; Rathmann W; Peters A; Koenig W; Thorand B
    PLoS One; 2011; 6(6):e19852. PubMed ID: 21674000
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.